Navigation Links
Hanger Reports Second Quarter 2013 Results
Date:7/31/2013

AUSTIN, Texas, July 31, 2013 /PRNewswire/ --

  • Reports adjusted diluted EPS of $0.52
  • Reports $0.40 diluted EPS
  • Achieves same center sales growth of 3.9%
  • Raises annual adjusted EPS guidance to range of $2.07-$2.13 to reflect the combined impact of debt refinancing and increased costs
  • Hanger, Inc. (NYSE: HGR) announced net sales of $273.7 million for the quarter ended June 30, 2013, an increase of $22.0 million, or 8.7%, from $251.7 million for the second quarter of 2012.
    Diluted earnings per share were $0.40 for the second quarter of 2013 compared to $0.50 for the same period of 2012.  Adjusted diluted earnings per share, which excludes costs related to acquisitions, implementation of the Company's new clinic management system (which the Company refers to as "Janus"), and debt issuance cost associated with the June 2013 refinancing of the Company's bank credit facilities, increased 2% to $0.52 for the second quarter of 2013 from $0.51 for the second quarter of 2012.

    "We are pleased with our overall sales performance in the quarter despite a difficult macro environment, but are not satisfied with our second quarter earnings," commented Vinit K. Asar, President and Chief Executive Officer of Hanger. "Same center sales in our Patient Care segment continued to be strong, delivering 3.9% growth in the quarter.  However, higher costs in the quarter related to increased Recovery Audit Contractor (RAC) audits, sequestration and employee benefits had a negative impact on operating margin of approximately 100 basis points compared to Q2 last year.  During the second half of 2013 we will remain sharply focused on the key value drivers of our business - same center sales and O&P acquisitions - while we weather regulatory pressures and cost increases with an increasing focus on reducing material costs and driving other effi
    '/>"/>

    SOURCE Hanger, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
    2. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
    3. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
    4. Hanger, Inc. Reports Earnings of $0.50 Per Diluted Share for the Second Quarter 2012
    5. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
    6. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
    7. Hanger, Inc. Has Record Year In O&P Acquisitions:
    8. Hanger Reports $0.62 Diluted EPS for the Fourth Quarter 2012
    9. Hanger Files Form 10-K for Year Ended December 31, 2012
    10. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
    11. Hanger Reports First Quarter 2013 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... , April 17, 2015 Nonin Medical, ... that President and Chief Operating Officer Steve Bucholz ... Isaacson is expanding his role as Chief Executive ... role as Chief Technology Officer. Operations will transition to ... " Steve Bucholz has been instrumental to Nonin ...
    (Date:4/17/2015)... WOONSOCKET, R.I , April 17, 2015 ... holding a conference call on Friday, May 1, 2015, ... discuss its first quarter financial results. An ... simultaneously through the Investor Relations portion of the CVS ... webcast, visit http://investors.cvshealth.com . This webcast will be ...
    (Date:4/17/2015)... ASSESS shows   plasma circulating ... viable alternative to tumour biopsy   IGNITE ... advanced NSCLC   AstraZeneca today presented results from ... DNA (ctDNA) testing for epidermal growth factor receptor (EGFR) mutation ... cancer (NSCLC) in clinical practice. [ 1 ] ...
    Breaking Medicine Technology:Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
    ... Makes Rapid Recovery after Procedure Utilizing IlluminOss(TM) Photodynamic ... Medical today announced that one of the leading ... performed the first case in the world utilizing ... orthopedic surgery. The IlluminOss Photodynamic Bone Stabilization ...
    ... Feb. 24 BioTrends is pleased to announce the fielding of ... (R) . Takeda Pharmaceutical Company Limited announced that they ... febuxostat) on February 13, 2009. Uloric (R) ... and represents the first product for gout that has been approved ...
    Cached Medicine Technology:IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile 2IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile 3
    (Date:4/18/2015)... (PRWEB) April 18, 2015 "I recognized ... stretchers in healthcare facilities," said an inventor from Cincinnati, ... storage system." , He developed the Slyde Door to ... used in healthcare facilities. It provides convenient storage space ... are more stretchers available for patients. , This ...
    (Date:4/18/2015)... has released a new blog post explaining how to ... Clients can review important auto insurance quotes online, by ... advantages for clients who need affordable financial security for ... coverage for their vehicles can purchase a policy at ... agencies offer important discounts and drivers can learn more ...
    (Date:4/18/2015)... April 18, 2015 Patients who undergo ... developing mesothelioma later in life, but the disease is ... that is unrelated to radiation. Surviving Mesothelioma has just ... website. Click here to read it now. ... the cases of 45 patients who had both a ...
    (Date:4/18/2015)... than 2000 styles of newly designed prom dresses are ... carrying celebrity inspired special occasion dresses. With the prom ... for their prom. For those who are still looking ... be an ideal choice. , "We have by ... the most loved styles seen at this years major ...
    (Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as part ... latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... In a turbulent world, people may find themselves in dangerous ... their first move, but some situations can be avoided if ...
    Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2
    ... days after trauma, developers say , WEDNESDAY, Sept. 12 ... monitor blood flow through the brain in real time, ... head injuries. , Brain trauma is a top killer ... suffer brain injuries annually, according to the U.S. Centers ...
    ... Scientists have identified a distinct subpopulation of cancer stem ... deadly human pancreatic cancer. The research, published by Cell ... Stem Cell, provides insight into the role of CSCs ... directions for development of more effective therapeutics. , Pancreatic ...
    ... - Treatment in private doctors, offices with FDA-approved medication could, ... ... killers-, RICHMOND, Va., Sept. 12 ... released by the Substance Abuse and,Mental Health Services Administration (SAMHSA), shows that ...
    ... EXTON, Pa., Sept. 12 Kensey Nash Corporation,(Nasdaq: ... earnings results,for its first quarter ended September 30, 2007 ... Joe Kaufmann, President and CEO, will be hosting ... 2007 at 9:00 A.M.,Eastern Time. To participate in ...
    ... against macular degeneration, study finds , WEDNESDAY, Sept. 12 ... the yellow plant pigments lutein and zeaxanthin may have ... a leading cause of irreversible blindness among the elderly. ... supported by the U.S. government, looked at more than ...
    ... 12, 2007 Rice University chemists have discovered a way ... onto tiny gold spheres. The result is a tiny ball, ... with the drug. , Paclitaxel, which is sold under the ... their inner works. , "Paclitaxel is one of the most ...
    Cached Medicine News:Health News:Imaging Software Helps Track, Treat Injured Brains 2Health News:Cancer stem cell subpopulation drives metastasis of human pancreatic cancer 2Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 2Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 3Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 4Health News:Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults 5Health News:Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference 2Health News:Taxol bristle ball: a wrench in the works for cancer 2
    ... double spot test is a rapid, ... antibodies to T. cruzi in human ... samples. This test is intended primarily ... reactive samples should be confirmed by ...
    ... is intended for the immunochromatographic, qualitative ... samples.,Smart Strip Gonorrhea is based on ... the determination of gonorrhea antigen in ... urinary system as an aid in ...
    Inquire...
    For the rapid determination of human chorionic gonadotropin (hCG) in urine and serum. The test strip is used to obtain a visual qualitative result....
    Medicine Products: